PLOS Neglected Tropical DiseasesMicrobiologyPeer-reviewed journal article
Chikungunya virus requires an intact microtubule network for efficient viral genome delivery
T. E. Hoornweg, E. M. Bouma, D. P. I. van de Pol, I. A. Rodenhuis-Zybert, J. M. Smit
Abstract
Chikungunya virus (CHIKV) is a re-emerging mosquito-borne virus, which has rapidly spread around the globe thereby causing millions of infections. CHIKV is an enveloped virus belonging to the Togaviridae family and enters its host cell primarily via clathrin-mediated endocytosis. Upon internalization, the endocytic vesicle containing the virus particle moves through the cell and delivers the virus to early endosomes where membrane fusion is observed. Thereafter, the nucleocapsid dissociates and the viral RNA is translated into proteins. In this study, we examined the importance of the microtubule network during the early steps of infection and dissected the intracellular trafficking behavior of CHIKV particles during cell entry. We observed two distinct CHIKV intracellular trafficking patterns prior to membrane hemifusion. Whereas half of the CHIKV virions remained static during cell entry and fused in the cell periphery, the other half showed fast-directed microtubule-dependent movement prior to delivery to Rab5-positive early endosomes and predominantly fused in the perinuclear region of the cell. Disruption of the microtubule network reduced the number of infected cells. At these conditions, membrane hemifusion activity was not affected yet fusion was restricted to the cell periphery. Furthermore, follow-up experiments revealed that disruption of the microtubule network impairs the delivery of the viral genome to the cell cytosol. We therefore hypothesize that microtubules may direct the particle to a cellular location that is beneficial for establishing infection or aids in nucleocapsid uncoating. Author SummaryChikungunya virus (CHIKV) is an alphavirus that is transmitted to humans by infected mosquitoes. Disease symptoms can include fever, rash, myalgia, and long-lasting debilitating joint pains. Unfortunately, there is currently no licensed vaccine or antiviral treatment available to combat CHIKV. Understanding the virus:host interactions during the replication cycle of the virus is crucial for the development of effective antiviral therapies. In this study we elucidated the trafficking behavior of CHIKV particles early in infection. During cell entry, CHIKV virions require an intact microtubule network for efficient delivery of the viral genome into the host cell thereby increasing the chance to productively infect a cell.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chikungunya Virus Release is Reduced by TIM-1 Receptors Through Binding of Envelope Phosphatidylserine
J. M. Reyes Ballista, A. J. Hoover, … M. A. Brindley·Journal of VirologyPeer-reviewed·Aug 20, 2024
- Chikungunya virus glycoproteins transform macrophages into productive viral dissemination vessels.
M. M. H. Li, Z. Yao, … J. A. Wohlschlegel·bioRxiv·May 29, 2023
- Phosphatidylserine within the Viral Membrane Enhances Chikungunya Virus Infectivity in a Cell-type Dependent Manner
K. L. Miazgowicz, J. M. Reyes Ballista, … M. A. Brindley·bioRxiv·Jan 14, 2022
- MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway
S. Chattopadhyay, P. Mamidi, … S. Chattopadhyay·bioRxiv·May 26, 2021
- In situ characterization of late Chikungunya virus replication organelle
Justine Girard, Olivier Le-Bihan, … Patrick Bron·bioRxiv·Feb 25, 2023
- Serotonergic drugs inhibit CHIKV infection at different stages of the cell entry pathway
E. M. Bouma, D. P. I. van de Pol, … J. M. Smit·bioRxiv·Mar 24, 2020